We are live on ! Find out more
MIH

Meitav Investment House Portfolio holdings

AUM $14.9B
1-Year Est. Return 46.8%
This Fund
S&P 500
This Quarter Est. Return
-13.94%
1 Year Est. Return
+46.8%
3 Year Est. Return
+131.39%
5 Year Est. Return
+140.78%
10 Year Est. Return
AUM
$1.62B
AUM Growth
-$435M
Cap. Flow
-$75.7M
Cap. Flow %
-4.68%
Top 10 Hldgs %
33.88%
Holding
478
New
36
Increased
85
Reduced
177
Closed
142

Sector Composition

Rank Sector Weight
1 Technology 29.3%
2 Healthcare 12.72%
3 Materials 5.4%
4 Communication Services 4.51%
5 Financials 3.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ITRN icon
76
Ituran Location and Control
ITRN
$1.02B
$2.66M 0.16%
82,747
-429
-0.5% -$14.4K
ASHR icon
77
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.59B
$2.66M 0.16%
121,050
+10,370
+9% +$241K
AKAM icon
78
Akamai
AKAM
$16.9B
$2.56M 0.16%
41,973
-5,710
-12% -$380K
KWEB icon
79
KraneShares CSI China Internet ETF
KWEB
$5.76B
$2.51M 0.16%
66,353
-584,824
-90% -$24.7M
ESLT icon
80
Elbit Systems
ESLT
$39.6B
$2.47M 0.15%
80,901
+8,604
+12% +$1.04M
NVMI
81
Nova
NVMI
$12.2B
$2.47M 0.15%
280,029
+52,089
+23% +$1.23M
SLGL icon
82
Sol-Gel Technologies
SLGL
$277M
$2.46M 0.15%
40,881
-69
-0.2% -$4.58K
MDWD icon
83
MediWound
MDWD
$178M
$2.42M 0.15%
84,996
+11,568
+16% +$449K
CHL
84
DELISTED
China Mobile Limited
CHL
$2.36M 0.15%
49,100
-19,300
-28% -$929K
FFIV icon
85
F5
FFIV
$23.2B
$2.3M 0.14%
14,171
-3,179
-18% -$545K
QQQ icon
86
Invesco QQQ Trust
QQQ
$479B
$2.29M 0.14%
14,934
-2,381
-14% -$398K
TRHC
87
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$2.29M 0.14%
37,000
+13,000
+54% +$921K
GMDA
88
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$2.24M 0.14%
+225,000
New +$2.44M
INGN icon
89
Inogen
INGN
$160M
$2.13M 0.13%
+17,364
New +$2.86M
MA icon
90
Mastercard
MA
$493B
$2.11M 0.13%
11,162
-5,382
-33% -$1.07M
ZNGA
91
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$2.03M 0.13%
515,731
-9,428
-2% -$35.7K
VBIV
92
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$2.02M 0.13%
42,179
-149
-0.4% -$8.17K
SSKN
93
DELISTED
Strata Skin Sciences
SSKN
$2.01M 0.12%
71,582
+35,056
+96% +$1M
AAPL icon
94
Apple
AAPL
$4.5T
$2M 0.12%
50,680
-322,568
-86% -$15.6M
CAMT icon
95
Camtek
CAMT
$7.38B
$1.94M 0.12%
288,660
-47,358
-14% -$367K
IBM icon
96
IBM
IBM
$223B
$1.92M 0.12%
17,685
-12,003
-40% -$1.44M
TDC icon
97
Teradata
TDC
$2.58B
$1.9M 0.12%
49,613
-8,343
-14% -$305K
V icon
98
Visa
V
$675B
$1.89M 0.12%
14,314
-7,022
-33% -$970K
CRM icon
99
Salesforce
CRM
$162B
$1.85M 0.11%
13,504
-5,862
-30% -$806K
TTE icon
100
TotalEnergies
TTE
$195B
$1.83M 0.11%
+3,216,038
New +$2.01M

Similar funds

Meitav Investment House's Q4 2018 Portfolio in Review

As of Q4 2018, Meitav Investment House held 478 positions worth $1.62B, down 21% from $2.05B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Meitav Investment House withdrew a net $75.7M in Q4 2018, closing 142 positions and reducing 177 holdings. Its most notable exit was State Street SPDR S&P Aerospace & Defense ETF, an estimated $26.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Healthcare and Materials.

Against the trend, Meitav Investment House opened a new position in KKR & Co worth $20.7M.

  • Meitav Investment House's largest Q4 2018 buy was KKR & Co: 1,053,701 shares worth $20.7M.
  • Meitav Investment House added most to iShares Core S&P 500 ETF in Q4 2018, an estimated $54.1M increase.
  • Meitav Investment House's biggest Q4 2018 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $32M.
  • Meitav Investment House fully exited State Street SPDR S&P Aerospace & Defense ETF in Q4 2018, selling an estimated $26.4M.
  • Meitav Investment House's ten largest holdings make up 34% of its $1.62B portfolio in Q4 2018.
  • Meitav Investment House opened 36 new positions and closed 142 in Q4 2018.
  • Meitav Investment House's portfolio value fell 21% quarter-over-quarter to $1.62B.

Based on Meitav Investment House's 13F filing for Q4 2018, filed 13 Feb 2019.